Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.5966 per ML under NDC 68462028132. Its NADAC has been published 104 times since Jul 3, 2024.

The High Outlier badge above means this manufacturer's average price in the Brimonidine Tartrate and Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$2.5966per ML
High Outlier

Strength

2; 5 mg/mL; mg/mL

NDC

68462028132

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214987

On Market Since

5/16/2024

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 104 times since Jul 3, 2024, and over the history we have for it it has declined 71.8%. The table below summarizes its recorded NADAC range and movement.

Current price$2.5966 per ML
All-time high$11.4034 (Sep 11, 2024)
All-time low$2.3704 (May 20, 2026)
52-week high$5.6921
52-week low$2.3704
Median price$5.6921
Average price$5.9774
Largest weekly change+32.4% (Oct 23, 2024)
Weeks tracked104
Tracking sinceJul 3, 2024

Price History

1W

0.0%

1M

+9.5%

3M

-0.9%

6M

-2.9%

1Y

-54.4%

3Y

N/A

5Y

N/A

All

-71.8%

Generic Alternatives

The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.5966 per ML (NDC 68462028132), effective Jun 24, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 71.8%. It has been tracked across 104 weekly CMS publications since Jul 3, 2024.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Jul 3, 2024, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $2.3704 (May 20, 2026) to a high of $11.4034 (Sep 11, 2024), with a median of $5.6921 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BRIMONIDINE-TIMOLOL 0.2%-0.5%, is $2.1018 per ML — about 19% below BRIMONIDINE-TIMOLOL 0.2%-0.5%.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 68462028132) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.